Page last updated: 2024-09-02

ramosetron and Genital Diseases, Female

ramosetron has been researched along with Genital Diseases, Female in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Do, SH; Hwang, JW; Jee, BC; Kim, K; Kim, YB; Lee, B; Lee, JR; No, JH; Shin, HJ; Suh, DH1

Trials

1 trial(s) available for ramosetron and Genital Diseases, Female

ArticleYear
Efficacy of Single-dose and 2-dose Intravenous Administration of Ramosetron in Preventing Postoperative Nausea and Vomiting After Laparoscopic Gynecologic Operation: A Randomized, Double-blind, Placebo-controlled, Phase 2 Trial.
    Surgical laparoscopy, endoscopy & percutaneous techniques, 2017, Volume: 27, Issue:3

    Topics: Administration, Intravenous; Adult; Antiemetics; Benzimidazoles; Double-Blind Method; Drug Administration Schedule; Female; Genital Diseases, Female; Humans; Laparoscopy; Pain, Postoperative; Postoperative Care; Postoperative Nausea and Vomiting; Treatment Outcome

2017